NCT07151599 Efficacy of Combined Fractional Er:Glass and Thulium Lasers Versus Microneedling for Atrophic Acne Scars
| NCT ID | NCT07151599 |
| Status | Recruiting |
| Phase | — |
| Sponsor | University of Nove de Julho |
| Condition | Acne Scars |
| Study Type | INTERVENTIONAL |
| Enrollment | 84 participants |
| Start Date | 2025-10-16 |
| Primary Completion | 2026-05 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 84 participants in total. It began in 2025-10-16 with a primary completion date of 2026-05.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The purpose of this study is to compare two treatments for acne scars on the face. The study will test whether fractional lasers (Erbium:Glass and Thulium) lead to better improvement in acne scars than microneedling.
Eligibility Criteria
Inclusion Criteria: * Fitzpatrick skin phototypes I to VI * Presence of atrophic acne scars on the face Exclusion Criteria: * Decompensated systemic diseases * Any active infection (e.g., viral such as herpes, bacterial, or fungal) * Pregnant or breastfeeding women * Presence of hypertrophic or keloid scars * Current use of anticoagulant or antiplatelet medications * History of hemophilia or coagulation disorders * Current use of anti-inflammatory drugs or corticosteroids * Use of retinoids, including isotretinoin, within the past 6 months * Exposure to sunlight within the past 15 days * Undergoing any aesthetic facial treatment or having undergone scar treatments in the facial region within 180 days prior to study initiation * Presence of active acne (occasional isolated lesions will not be considered exclusion criteria)
Contact & Investigator
Christiane Pavani, PhD
STUDY CHAIR
University of Nove de Julho
Frequently Asked Questions
Who can join the NCT07151599 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, up to 45 Years, studying Acne Scars. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT07151599 currently recruiting?
Yes, NCT07151599 is actively recruiting participants. Contact the research team at lucianacamargo@uni9.edu.br for enrollment information.
Where is the NCT07151599 trial being conducted?
This trial is being conducted at São Paulo, Brazil.
Who is sponsoring the NCT07151599 clinical trial?
NCT07151599 is sponsored by University of Nove de Julho. The principal investigator is Christiane Pavani, PhD at University of Nove de Julho. The trial plans to enroll 84 participants.